Cynosure Advisors’s Johnson & Johnson JNJ Stock Holding History

Cynosure Advisors’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-7,042	Closed	-$854K	–	108
2018 Q2	$854K	Sell	7,042 -1,701	-19%	-$212K	0.23%	51
2018 Q1	$1.12M	Sell	8,743 -2,034	-19%	-$275K	0.28%	38
2017 Q4	$1.51M	Buy	+10,777	New	+$1.5M	0.35%	22

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Cynosure Advisors's JNJ Position: Q3 2018 in Review

Cynosure Advisors sold out of Johnson & Johnson (JNJ) in Q3 2018, closing a stake of 7,042 shares — an estimated $854K sold.

Cynosure Advisors first reported a position in JNJ in Q4 2017 and held it in 3 quarters. The position peaked at $1.51M in Q4 2017. 2,583 funds tracked by Wall St. Rank hold JNJ as of Q3 2018.

Cynosure Advisors reported no remaining Johnson & Johnson position as of Q3 2018 after selling out during the quarter.
Cynosure Advisors sold 7,042 Johnson & Johnson shares in Q3 2018, an estimated $854K.
Cynosure Advisors first reported a position in Johnson & Johnson in Q4 2017 and held it in 3 quarters.
Cynosure Advisors's Johnson & Johnson position peaked at $1.51M in Q4 2017.
2,583 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2018.

Based on Cynosure Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.